Quell Therapeutics

About Quell Therapeutics

Quell Therapeutics is a clinical-stage biotechnology company developing therapies that use a patient’s own regulatory T cells (Tregs) to restore immune tolerance and treat severe immune and inflammatory diseases. The company focuses on engineering Tregs to provide durable immune control, with potential applications in autoimmune conditions and organ transplantation. Headquartered in the United Kingdom, Quell aims to transform outcomes for patients with immune-mediated diseases by advancing Treg-based approaches from discovery to clinical development.